INCYTE CORP (INCY)
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Address
1801 AUGUSTINE CUT-OFF
WILMINGTON, DE 19803
Founded
1991
Number of Employees
2,524
Website
http://www.incyte.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | - | - | - | $1,999,551 | $1,999,551 |
| Average Price | - | - | - | - | - | - | - | - | - | - | $60.00 | $60.00 |
| # Shares Purchased | - | - | - | - | - | - | - | - | - | - | 33,325,849 | 33,325,849 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | - | - | 5.0% | 5.0% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | - | - | 7.4% | 7.4% |
| Excess Total Return | - | - | - | - | - | - | - | - | - | - | -2.4% | -2.4% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | - | - | 52% | 45% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at INCY make a trade.
Creating a free account takes less than one minute